Cetera Investment Advisers
EBS icon

Cetera Investment Advisers’s Emergent Biosolutions EBS Stock Holding History

Cetera Investment Advisers’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$807K Sell
96,301
-129,182
-57% -$1.08M ﹤0.01% 3240
2026
Q1 		$1.87M Buy
225,483
+6,000
+3% +$62.1K ﹤0.01% 2335
2025
Q4 		$2.71M Buy
219,483
+3,489
+2% +$37.4K ﹤0.01% 1951
2025
Q3 		$1.91M Sell
215,994
-142,958
-40% -$1.11M ﹤0.01% 2208
2025
Q2 		$2.29M Buy
358,952
+2,671
+0.7% +$15.3K ﹤0.01% 1743
2025
Q1 		$1.73M Buy
356,281
+79,034
+29% +$654K ﹤0.01% 1847
2024
Q4 		$2.65M Sell
277,247
-107,236
-28% -$984K 0.01% 1445
2024
Q3 		$3.21M Buy
384,483
+257,852
+204% +$2.34M 0.01% 1277
2024
Q2 		$864K Sell
126,631
-44,320
-26% -$191K ﹤0.01% 2184
2024
Q1 		$433K Buy
+170,951
New +$385K ﹤0.01% 2719

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Cetera Investment Advisers's EBS Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Emergent Biosolutions (EBS) stake by 57% in Q2 2026, selling an estimated $1.08M and leaving 96,301 shares worth $807K. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

Cetera Investment Advisers first reported a position in EBS in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.21M in Q3 2024. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Cetera Investment Advisers held 96,301 shares of Emergent Biosolutions worth $807K as of Q2 2026.
  • Cetera Investment Advisers sold 129,182 Emergent Biosolutions shares in Q2 2026, an estimated $1.08M.
  • Emergent Biosolutions made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3240 holding.
  • Cetera Investment Advisers first reported a position in Emergent Biosolutions in Q1 2024 and has held it in 10 quarters since.
  • Cetera Investment Advisers's Emergent Biosolutions position peaked at $3.21M in Q3 2024.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.